“In a world where we have so many wearables — smart rings, watches, glucose sensors — it’s challenging to integrate all of this information,” say Biolinq founder Jared Tangney and CEO Rich Yang. “So we decided to make it available to everybody in one device.” In this Vanguards of Health Care episode, the pair speak with Bloomberg Intelligence’s analyst Matt Henriksson about Biolinq’s microsensor-based patch that uses silicon semiconductor technology to track glucose and potentially other biomarkers. They also discuss the company’s commercial strategy for type 2 diabetes patients following its FDA de Novo approval, a US regulatory designation granted to first-of-its-kind medical devices that have been shown to be safe and effective.

&ldquo;In a world where we have so many wearables &mdash; smart rings, watches, glucose sensors &mdash; it&rsquo;s challenging to integrate all of this information,&rdquo; say&nbsp;Biolinq&nbsp;founder&nbsp;Jared Tangney&nbsp;and CEO&nbsp;Rich Yang. &ldquo;So we decided to make it available to everybody in one device.&rdquo; In this&nbsp;Vanguards of Health Care&nbsp;episode, the pair speak with Bloomberg Intelligence&rsquo;s analyst&nbsp;Matt Henriksson&nbsp;about Biolinq&rsquo;s microsensor-based patch that uses silicon semiconductor technology to track glucose and potentially other biomarkers. They also discuss the company&rsquo;s commercial strategy for type 2 diabetes patients following its FDA de Novo approval, a US regulatory designation granted to first-of-its-kind medical devices that have been shown to be safe and effective.

Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Vanguards of Health Care by Bloomberg Intelligence

Biolinq Introduces New Silicon Tech Opens Next Chapter of Glucose and Analyte Detection

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9807abec-35b4-4bcc-9076-b38d00d9bce0/transcript

Advertisement